Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
批准号:
8245631
负责人:
James Michael Fleckenstein
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-10-01 至 2016-09-30
关键词:
AddressAdherenceAdhesionsAntigensAreaBacteriaBacterial AdhesinsCell CommunicationCell Cycle KineticsCell LineCell Surface ReceptorsCellsCholeraComplexCytolysisDNA Microarray ChipDataDeveloped CountriesDevelopmentDiarrheaDiseaseDisease OutbreaksEnteralEpithelialEpithelial CellsEscherichia coliEscherichia coli InfectionsEscherichia coli VaccinesEventFailureFlagellaGenesGenetic TranscriptionGoalsHealthHeatingHeterogeneityHumanImageImmune responseInfectionIntestinesInvestigationKineticsLabelLaboratoriesMembraneMethodologyMicroscopyMolecularMorbidity - disease rateNatureNew AgentsOrganismPathogenesisPlasmidsPreventionPrevention approachProteinsPseudomonasResearchRoleSoldierStructureSurfaceToxinTranslatingUnited StatesUrinary tract infectionVaccinesVeteransVirulenceVirulence Factorsdesignenteric pathogenenterotoxigenic Escherichia colifimbriafoodborne outbreakglobal healthimmunogenicinsightmortalitynovelnovel strategiespathogenpathogenic Escherichia colipublic health relevancerelease factorresearch and developmentresponsetime usetoolvaccine development
中文摘要
描述(由申请人提供):
产肠毒素大肠杆菌(ETEC)是一种遗传多样的致病性大肠杆菌。这种大肠杆菌在全世界范围内引起了数量惊人的腹泻病例,并已成为美国大规模腹泻爆发的原因。 这些生物体都具有产生、分泌和递送热稳定(ST)和/或热不稳定(LT)毒素到肠衬里细胞的能力,最终导致腹泻,其可能是严重的和霍乱样的。 在发现这些产毒大肠杆菌后不久,质粒上编码的毒素基因被鉴定出来。40多年前, 直到最近,大多数关于ETEC的研究都集中在少数分子上,即毒素本身和质粒编码的指状定植因子(CF)。不幸的是,仅以这些抗原为中心的疫苗开发已被证明是非常具有挑战性的,部分原因是CF分子的异质性以及毒素似乎不能提供针对疾病的完全保护(在LT的情况下)或不是免疫原性的(如ST的情况)。 最近几个疫苗的失败,这些抗原,促使寻找替代策略,并返回到基本的发病机制研究,以解决我们的理解这些全球重要的病原体如何导致疾病的差距。 虽然人们对这些毒素进入宿主细胞后的分子作用了解很多,但对细菌如何有效地将这些毒素传递到其各自的细胞表面受体却知之甚少。 这些研究将使用最近开发的分子工具,利用新试剂的最新发现,并利用最先进的方法来定义ETEC表面上促进这些毒素有效递送的新型分子的滚动。这些研究的长期目标是将这些信息转化为安全、有效和广泛保护的ETEC疫苗的合理设计。
英文摘要
DESCRIPTION (provided by applicant):
The enterotoxigenic Escherichia coli (ETEC) are a genetically diverse type of pathogenic E. coli that cause astounding numbers of cases of diarrheal illness worldwide, and have emerged as a cause of large-scale outbreaks of diarrhea in the United States. These organisms share the ability to produce, secrete, and deliver heat-stable (ST) and/or heat-liable (LT) toxins to the intestinal lining cells ultimately causing diarrhea, which can be severe and cholera-like. The toxin genes encoded on plasmids, were identified shortly after the discovery of these toxin-producing E. coli more than 40 years ago. Most research on ETEC until very recently focused on a small number of molecules, namely the toxins themselves and plasmid-encoded fingerlike colonization factors (CFs). Unfortunately, vaccine development centered on these antigens alone has proven to be very challenging in part because of the heterogeneity of the CF molecules and the fact that the toxins do not appear to afford complete protection against disease (in the case of LT), or are not immunogenic (as is the case for ST). The recent failure of several vaccines incorporating these antigens has prompted both a search for alternative strategiesand a return to basic pathogenesis studies in order to address gaps in our understanding of how these globally important pathogens cause disease. While much is known about the molecular action of these toxins once they enter host cells, very little is known about how the bacteria effectively deliver these toxins to their respective cell surface receptors. These studies will use recently developed molecular tools, capitalize on recent discoveries of new agents, and exploit the state-of-the-art methodology to define the roll of novel molecules on the surface of ETEC that promote the effective delivery of these toxins. The long-term goal of these studies is to translate this information into rational design of a safe, effective, and broadly protective ETEC vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Pathogenesis of enterotoxigenic E. coli associated enteropathy
-
批准号:10656056
-
项目类别:
-
资助金额:$64.46万
-
财政年份:2023
-
负责人:James Michael Fleckenstein
-
依托单位:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
-
批准号:9884089
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:James Michael Fleckenstein
-
依托单位:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
-
批准号:10438532
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:James Michael Fleckenstein
-
依托单位:
ShEEP Request for ImageXpress Micro Confocal High Content Screening System
-
批准号:10177122
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:James Michael Fleckenstein
-
依托单位:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
-
批准号:10553173
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:James Michael Fleckenstein
-
依托单位:
Molecular Microbiology of Enterotoxigenic E. coli Pathogen-Host Interactions
-
批准号:9926220
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2016
-
负责人:James Michael Fleckenstein
-
依托单位:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
-
批准号:9275348
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:James Michael Fleckenstein
-
依托单位:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
-
批准号:8965936
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:8436769
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:8680121
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:8098951
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:9116756
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:8305626
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an enterotoxigenic E coli vaccine
-
批准号:10368958
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:8487344
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:9204731
-
项目类别:
-
资助金额:$49.49万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
-
批准号:7947166
-
项目类别:
-
资助金额:$40.58万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
Novel Antigen Identification for an enterotoxigenic E coli vaccine
-
批准号:10576881
-
项目类别:
-
资助金额:$60.79万
-
财政年份:2010
-
负责人:James Michael Fleckenstein
-
依托单位:
PATHOGENESIS OF ETEC INFECTIONS
-
批准号:6903446
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2001
-
负责人:James Michael Fleckenstein
-
依托单位:
PATHOGENESIS OF ETEC INFECTIONS
-
批准号:6784691
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2001
-
负责人:James Michael Fleckenstein
-
依托单位:
海外基金